The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device

被引:234
作者
Baker, Alexander N. [1 ]
Richards, Sarah-Jane [1 ]
Guy, Collette S. [1 ,2 ]
Congdon, Thomas R. [1 ]
Hasan, Muhammad [1 ]
Zwetsloot, Alexander J. [3 ]
Gallo, Angelo [1 ]
Lewandowski, Jozef R. [1 ]
Stansfeld, Phillip J. [1 ,2 ]
Straube, Anne [3 ]
Walker, Marc [4 ]
Chessa, Simona [5 ]
Pergolizzi, Giulia [5 ]
Dedola, Simone [5 ]
Field, Robert A. [5 ,6 ,7 ]
Gibson, Matthew, I [1 ,3 ]
机构
[1] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England
[2] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England
[3] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England
[4] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England
[5] Iceni Diagnost Ltd, Norwich NR4 7GJ, Norfolk, England
[6] Univ Manchester, Dept Chem, Manchester M1 7DN, Lancs, England
[7] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England
基金
英国工程与自然科学研究理事会; 英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
GOLD NANOPARTICLES; RECEPTOR; CORONAVIRUS; SPECIFICITY; STABILITY; TESTS; ASSAY; COV;
D O I
10.1021/acscentsci.0c00855
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
There is an urgent need to understand the behavior of of the novel coronavirus (SARS-COV-2), which is the causative agent of COVID-19, and to develop point-of-care diagnostics. Here, a glyconanoparticle platform is used to discover that N-acetyl neuraminic acid has affinity toward the SARS-COV-2 spike glycoprotein, demonstrating its glycan-binding function. Optimization of the particle size and coating enabled detection of the spike glycoprotein in lateral flow and showed selectivity over the SARS-COV-1 spike protein. Using a virus-like particle and a pseudotyped lentivirus model, paper-based lateral flow detection was demonstrated in under 30 min, showing the potential of this system as a low-cost detection platform.
引用
收藏
页码:2046 / 2052
页数:7
相关论文
共 46 条
[1]   High-Affinity Glycopolymer Binding to Human DC-SIGN and Disruption of DC-SIGN Interactions with HIV Envelope Glycoprotein [J].
Becer, C. Remzi ;
Gibson, Matthew I. ;
Geng, Jin ;
Ilyas, Rebecca ;
Wallis, Russell ;
Mitchell, Daniel A. ;
Haddleton, David M. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (43) :15130-15132
[2]   SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission [J].
Bolles, Meagan ;
Donaldson, Eric ;
Baric, Ralph .
CURRENT OPINION IN VIROLOGY, 2011, 1 (06) :624-634
[3]   A Protein-Based Pentavalent Inhibitor of the Cholera Toxin B-Subunit [J].
Branson, Thomas R. ;
McAllister, Tom E. ;
Garcia-Hartjes, Jaime ;
Fascione, Martin A. ;
Ross, James F. ;
Warriner, Stuart L. ;
Wennekes, Tom ;
Zuilhof, Han ;
Turnbull, W. Bruce .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (32) :8323-8327
[4]   Bacterial toxin inhibitors based on multivalent scaffolds [J].
Branson, Thomas R. ;
Turnbull, W. Bruce .
CHEMICAL SOCIETY REVIEWS, 2013, 42 (11) :4613-4622
[5]   Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray [J].
Childs, Robert A. ;
Palma, Angelina S. ;
Wharton, Steve ;
Matrosovich, Tatyana ;
Liu, Yan ;
Chai, Wengang ;
Campanero-Rhodes, Maria A. ;
Zhang, Yibing ;
Eickmann, Markus ;
Kiso, Makoto ;
Hay, Alan ;
Matrosovich, Mikhail ;
Feizi, Ten .
NATURE BIOTECHNOLOGY, 2009, 27 (09) :797-799
[6]  
Clausen TM, 2020, CELL, V183, P1043, DOI [10.1101/2020.07.14.201616, 10.1016/j.cell.2020.09.033]
[7]   RECEPTOR SPECIFICITY IN HUMAN, AVIAN, AND EQUINE H2 AND H3 INFLUENZA-VIRUS ISOLATES [J].
CONNOR, RJ ;
KAWAOKA, Y ;
WEBSTER, RG ;
PAULSON, JC .
VIROLOGY, 1994, 205 (01) :17-23
[8]  
Crane MM, 1969, Patent No. [US3579306A, 3579306]
[9]   Lectin-based lateral flow assay: proof-of-concept [J].
Damborsky, Pavel ;
Koczula, Katarzyna M. ;
Gallotta, Andrea ;
Katrlik, Jaroslav .
ANALYST, 2016, 141 (23) :6444-6448
[10]   Cost benefit analysis of malaria rapid diagnostic test: the perspective of Nigerian community pharmacists [J].
Ezennia, Ifeoma Jovita ;
Nduka, Sunday Odunke ;
Ekwunife, Obinna Ikechukwu .
MALARIA JOURNAL, 2017, 16 :1-10